文献速递头颈神经MR

合成MRI与酰胺质子转移加权MRI鉴别鼻腔鼻窦良恶性病变

Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.
PubMed 文献 · Eur Radiol · 2024-03-16

回顾性分析80例鼻腔鼻窦病变患者(恶性31例、良性49例)的合成MRI与酰胺质子转移加权MRI定量参数,良性病变T1、T2、PD均值显著高于恶性病变而APT%相对较低,联合多参数模型AUC达0.866,优于任一单参数。

要点

  • 良性鼻腔鼻窦病变的合成MRI定量T1、T2、PD均值显著高于恶性病变(p<0.05)。
  • 恶性病变APT%相对低于良性病变,单参数AUC范围0.677–0.781,T2值诊断效能最佳。
  • 合成MRI多参数联合APT%的AUC为0.866,显著优于任一单参数(p<0.05)。

核心结论

  • 合成MRI联合酰胺质子转移加权成像有潜力反映组织内在特征,有助于鉴别鼻腔鼻窦良恶性病变。

研究设计与样本

  • 回顾性分析80例接受合成MRI与APTw检查的鼻腔鼻窦病变患者,其中恶性31例、良性49例;通过勾画感兴趣区获取T1、T2、质子密度(PD)及APT%,采用独立样本t检验或Wilcoxon检验比较两组,并行ROC曲线、Delong检验及logistic回归分析评估单参数与多参数模型的诊断效能。

关键影像表现/征象

  • 良性鼻腔鼻窦病变的合成MRI衍生T1、T2、PD均值显著高于恶性病变(p<0.05)。
  • 良性病变的APT%相对低于恶性病变(p<0.05)。

诊断标准与关键数值

  • 合成MRI衍生定量参数(T1、T2、PD)及APT%鉴别良恶性鼻腔鼻窦病变的AUC范围为0.677–0.781。
  • 单参数中T2值对鉴别良恶性病变的诊断效能最佳。
  • 合成MRI多参数联合APT%的AUC为0.866,高于任一单参数,且差异有统计学意义(p<0.05)。

临床应用与阅片要点

  • 合成MRI联合APTw成像可作为定量、无对比剂的方法,用于鉴别鼻腔鼻窦良恶性病变。
  • 该联合方法有助于克服内镜下鼻部取样表浅相关的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To explore the value of the synthetic MRI (SyMRI), combined with amide proton transfer-weighted (APTw) MRI for quantitative and morphologic assessment of sinonasal lesions, which could provide relative scale for the quantitative assessment of tissue properties.

METHODS: A total of 80 patients (31 malignant and 49 benign) with sinonasal lesions, who underwent the SyMRI and APTw examination, were retrospectively analyzed. Quantitative parameters (T1, T2, proton density (PD)) and APT % were obtained through outlining the region of interest (ROI) and comparing the two groups utilizing independent Student t test or a Wilcoxon test. Receiver operating characteristic curve (ROC), Delong test, and logistic regression analysis were performed to assess the diagnostic efficiency of one-parameter and multiparametric models.

RESULTS: SyMRI-derived mean T1, T2, and PD were significantly higher and APT % was relatively lower in benign compared to malignant sinonasal lesions (p < 0.05). The ROC analysis showed that the AUCs of the SyMRI-derived quantitative (T1, T2, PD) values and APT % ranged from 0.677 to 0.781 for differential diagnosis between benign and malignant sinonasal lesions. The T2 values showed the best diagnostic performance among all single parameters for differentiating these two masses. The AUCs of combined SyMRI-derived multiple parameters with APT % (AUC = 0.866) were the highest than that of any single parameter, which was significantly improved (p < 0.05).

CONCLUSION: The combination of SyMRI and APTw imaging has the potential to reflect intrinsic tissue characteristics useful for differentiating benign from malignant sinonasal lesions.

CLINICAL RELEVANCE STATEMENT: Combining synthetic MRI with amide proton transfer-weighted imaging could function as a quantitative and contrast-free approach, significantly enhancing the differentiation of benign and malignant sinonasal lesions and overcoming the limitations associated with the superficial nature of endoscopic nasal sampling.

KEY POINTS: • Synthetic MRI and amide proton transfer-weighted MRI could differentiate benign from malignant sinonasal lesions based on quantitative parameters. • The diagnostic efficiency could be significantly improved through synthetic MRI + amide proton transfer-weighted imaging. • The combination of synthetic MRI and amide proton transfer-weighted MRI is a noninvasive method to evaluate sinonasal lesions.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Xiang Y, Zhang Q, Chen X, et al. Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions. Eur Radiol. 2024. PMID: 38491129. doi:10.1007/s00330-024-10696-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。